Galapagos NV
GLPG
#4563
Rank
C$2.91 B
Marketcap
C$43.64
Share price
-0.57%
Change (1 day)
15.49%
Change (1 year)

Galapagos NV (GLPG) - Total debt

Total debt on the balance sheet as of September 2025 : C$12.16 Million

According to Galapagos NV's latest financial reports the company's total debt is C$12.16 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

Galapagos NV - Total debt on balance sheet (from 2008 to 2025)

Total debt by year

Year Total debt Change
2024-12-31C$17.5 M24.41%
2023-12-31C$14.06 M-55.86%
2022-12-31C$31.87 M-17.77%
2021-12-31C$38.76 M-16.03%
2020-12-31C$46.16 M24.3%
2019-12-31C$37.13 M
2018-12-31N/A-100%
2017-12-31C$0.01 M-84.75%
2016-12-31C$0.08 M-48.95%
2015-12-31C$0.17 M-26%
2014-12-31C$0.23 M-59.2%
2013-12-31C$0.57 M8.45%
2012-12-31C$0.53 M-53.96%
2011-12-31C$1.15 M-30.09%
2010-12-31C$1.65 M-26.01%
2009-12-31C$2.23 M-21.94%
2008-12-31C$2.86 M-54.96%
2007-12-31C$6.36 M-46.68%
2006-12-31C$11.93 M8.6%
2005-12-31C$10.98 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
AstraZeneca
AZN
C$45.08 B 370,540.02%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
C$63.26 B 520,047.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
C$35.27 B 289,889.02%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
C$94.96 B 780,695.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
C$95.62 M 686.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
C$17.87 B 146,886.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$23.58 B 193,818.15%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
C$32.96 B 270,928.81%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
C$57.15 B 469,833.20%๐Ÿ‡บ๐Ÿ‡ธ USA